NanoEcho

0,05 SEK

0,00%

Mindre end 1K følgere

NANECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

0,00 %
+64,90 %
-30,03 %
-34,29 %
-25,29 %
-54,90 %
-
-
-66,79 %

NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.

Læs mere
Markedsværdi
23,2 mio. SEK
Aktieomsætning
31,16 t SEK
Omsætning
488 t
EBIT %
-3.030,53 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning t

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
30.4
2026

Delårsrapport Q1'26

28.5
2026

Generalforsamling '26

25.8
2026

Delårsrapport Q2'26